There was plenty of FDA news this year not related to COVID-19.
Below is a list of Healio stories published in 2022 about FDA approvals and authorizations not related to COVID-19.
Virologically suppressed adults can now receive HIV treatment as few as six times per year following the February FDA approval of a 2-month dosing regimen for Cabenuva — which includes shots of cabotegravir (ViiV Healthcare) and replevining (Janssen Pharmaceuticals) — for virologically suppressed adults on a stable regimen with no history of prior treatment failure or resistance to either drug. Read more.